Comparative assessment of the effectiveness of modern neuroprotectors in conditions of experimental chronic cerebral ischemia

Authors

  • A. V. Demchenko
  • І. F. Belenichev

DOI:

https://doi.org/10.14739/2310-1210.2015.2.42042

Keywords:

Brain Ischemia, Cytidine-5'-diphosphate-choline, Cortexin, Tiocetam

Abstract

Modern pharmacological influence on the pathological changes in cerebral ischemia is actual task of the modern neurology.

Aim. To make a comparative assessment of the effectiveness of modern neuroprotectors in conditions of experimental chronic cerebral ischemia.

Methods and results. Experimental study of the neuroprotective effects of the citicoline, cortexin and tiocetam on the cognitive functions on the model of the chronic cerebral ischemia was conducted on 75 white rats. Biochemical, immunoassay, pharmacological, statistical methods were used.

Conclusion. Obtained results showed citicoline, cortexin and tiocetam ability to positively influence on the molecular-biochemical changes in the brain cortex with ischemia. This resulted in the glutathione-dependent enzymes activity increase, recover of the thiol-disulfide system balance, nitrotyrosine concentration decrease, improvement of the cognitive function in the experimental animals.

References

Barkhatov, D. Yu., Glotova, N. A., Konovalov, R. N., Fedin, P. A., Gur'ev, M. N., & Tanashyan M. M. (2011). E'ffektivnost' nejroprotekcii u bol'nykh s khronicheskimi cerebrovaskulyarnymi zabolevaniyami [Efficiency of neuroprotection among patients with chronical cerebrovascular diseases]. Mіzhnarodnyi nevrolohіchnyi zhurnal, 7(45), 37–42. [in Ukrainian].

Byelenіchev, I. F., Chernij, V. I., & Kolesnik, Yu. M. (2009). Racionalnaya nejroprotekciya [Rational neuroprotection]. Doneck: Zaslavskij. [in Ukrainian].

Bobrova, V. I., Kolesnik, Yu. M., Belenichev, I. F., & Demchenko, A. V. (2010). Tiocetam v kompleksnoj terapii khronicheskoj ishemii mozga [Tiocetam in complex therapy of chronic brain ischemia]. Zaporozhskij medicinskij zhurnal, 12(5), 130–135. [in Ukrainian].

Buresh, Ya., Bureshova, O., & H'yuston, D. (1991). Metodiki i osnovnye e`ksperimenty po izucheniyu mozga i povedeniya [Methods and principle experiments of studing brain and behaviour]. Moscow: Vysshaya shkola. [in Russian].

Madzhidova, Yo. N., & Usmanova, D. D. (2012). E`ffektivnost' korteksina v korrekcii kognitivnykh rasstrojstv u pacientov s khronicheskoj ishemiej mozga [Efficiency of cortexin in cognitive diseases correction among patients with chronical cerebral ischemia]. Mіzhnarodnyj nevrolohіchnyj zhurnal, 4(50), 48–50. [in Ukrainian].

Chekman, I. S., Gubskij, Yu. I., & Belenichev, I. F. (2010). Doklinicheskoe izuchenie specificheskoj aktivnosti potencial'nykh nejroprotektivnykh preparatov [Pre-clinical studying of potential neuroprotecor medicines specific activity]. Кyiv: GFC MZ Ukrainy. [in Ukrainian].

Adibhafla, R. M., & Hatcher, J. F. (2005). Citidine 5-diphosphocholine (CDP-Choline) insfrokeandofher CNS disorders. Neurochemical Research, 30, 15–23.

Dhar-Mascareño, M., Carcamo, J. M., & Golde, D. W. (2005). Hypoxia-reoxygenationinduced mitochondrial damage and apoptosis in human endothelial cells are inhibited by vitamin C. Free Radic Biol Med, 38, 1311–1322.

Liu, H., Wang, H., Shenvi, S., Hagen, T. M., & Liu, R. M. (2004). Glutathione metabolism during aging and in Alzheimer disease. Ann. N. Y. Acad. Ski, 1019, 346–349. doi: 10.1196/annals.1297.059.

Lowry, O. H., Rosebrough, N. J., Farr, A. L., & Randall R.J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265–275.

Downloads

How to Cite

1.
Demchenko AV, Belenichev ІF. Comparative assessment of the effectiveness of modern neuroprotectors in conditions of experimental chronic cerebral ischemia. Zaporozhye Medical Journal [Internet]. 2015Apr.27 [cited 2024Dec.24];17(2). Available from: http://zmj.zsmu.edu.ua/article/view/42042

Issue

No. 2 (2015): Zaporozhye medical journal

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)